Cholangiocarcinoma Drugs Market Size, Share & Industry Analysis, By Therapy (Chemotherapy, Immunotherapy, Targeted Therapy, & Others), By Drug Class (Antimetabolites, Platinum Compounds, PD-L1 Inhibitors, FGFR Inhibitors, IDH1 Inhibitors, PD-1 Inhibitors, & Others), By Disease Indication (Intrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma, Distal Cholangiocarcinoma, Advanced/Recurrent Cholangiocarcinoma, & Others), By Age Group (Pediatric & Adult), By Type (Branded & Generic), By Route of Administration (Oral & Parenteral), By Distribution Channel, and Regional Forecast, 2026-2034